Safety and Preliminary Efficacy in Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Lisocabtagene Maraleucel (Liso-Cel) in TRANSCEND NHL 001

[Anonymous]

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019; 17 (8): 8